Navigation Links
CPHI to Hold First Quarter of Fiscal Year 2013 Earnings Conference Call on Wednesday, May 15, 2013 at 8:30 a.m. ET
Date:5/6/2013

HAIKOU CITY, China, May 6, 2013 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its  fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans to hold its first quarter of year 2013 earnings conference call on Wednesday, May 15, 2013 at 8:30 a.m. ET.

Listeners may access the call by dialing 1-866-519-4004 or 65-672-393-81 for international callers, Conference ID # 59804293. A webcast will also be available through CPHI's website at http://www.chinapharmaholdings.com. A replay of the call will be accessible through May 22, 2013 by dialing 1-855-452-5696 or 61-281-990-299 for international callers, Conference ID # 59804293.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a rapidly growing specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high-margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com. The Company routinely posts important information on its
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Alimera Sciences To Release First Quarter Fiscal Year 2013 Financial Results
2. Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
3. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
4. BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2013 Financial Results on Friday, May 10, 2013
5. Lexicon to Report First Quarter Financial Results on May 10, 2013
6. Nektar to Announce Financial Results for the First Quarter of 2013 on Thursday, May 9, 2013, After Close of U.S.-Based Financial Markets
7. Volcano Announces First Quarter Results
8. IRIDEX Reports 2013 First Quarter Results
9. Masimo Reports First Quarter 2013 Financial Results
10. China Biologic Products to Report First Quarter 2013 Financial Results
11. Genomic Health Announces First Quarter 2013 Financial Results and Business Progress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 , Joint ... Ra from Biostar , Published in ,Stem Cells ... of lifespan through multiple IV administration of Adipose-derived MSC ... life expectancy found , Commercialization within 5 years ... the possibility that adult mesenchymal stem cells (MSCs) may ...
(Date:8/28/2015)... Massachusetts y LONDRES, 28 de agosto ... AEX: PHIA) anunció hoy su participación en el  ... exhibirá sus soluciones cardiológicas más recientes y novedosas, ... Cardiovascular, que conectan a las personas y la ... de ayudar a diagnosticar, guiar los tratamientos y ...
(Date:8/28/2015)... -- The global mHealth market ... 2020, growing at a CAGR of 47.6% from 2013 ... View Research, Inc. Monitoring services is expected to grow ... 2020.      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ... of chronic diseases such as cancer, heart ailments, and ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5
... SAN FRANCISCO , June 1 Prostate ... on FIRMAGON® (degarelix for injection) after one year of ... results of a Phase III extension study(1) presented here ... commonly used in monitoring prostate cancer patients, treatment response, ...
... , MORRISTOWN, N.J. , June 1 Watson ... Laboratories, Inc. has filed with the Securities and Exchange Commission a ... announced agreement under which Watson would acquire the U.S. rights to ... of Columbia common stock.   , ...
Cached Medicine Technology:Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 2Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 3Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 4Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 5Watson Confirms Columbia Laboratories' Filing of Definitive Proxy Relating to Watson's Acquisition of U.S. Rights to CRINONE® Progesterone Gel Product Line 2Watson Confirms Columbia Laboratories' Filing of Definitive Proxy Relating to Watson's Acquisition of U.S. Rights to CRINONE® Progesterone Gel Product Line 3Watson Confirms Columbia Laboratories' Filing of Definitive Proxy Relating to Watson's Acquisition of U.S. Rights to CRINONE® Progesterone Gel Product Line 4Watson Confirms Columbia Laboratories' Filing of Definitive Proxy Relating to Watson's Acquisition of U.S. Rights to CRINONE® Progesterone Gel Product Line 5
(Date:8/29/2015)... ... August 29, 2015 , ... "I have been a licensed ... "I specialize in manual therapy, and my invention will provide headache sufferers a ... additional muscle dysfunction throughout the body." , They developed THE RELIEVER to alleviates ...
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder and President ... to increase acceptance of the chiropractic field in the military. All too often VA ... Although Chiropractic was made available to the VA program over a decade ago, the ...
(Date:8/29/2015)... CA (PRWEB) , ... August 29, 2015 , ... ProDrop ... X . Each preset contains 15 seconds of unique footage that users can shrink ... rise, fall, zoom, attract and more. Users can customize color, brightness, scale, speed, range, ...
(Date:8/29/2015)... ... ... The popular television program VOICES IN AMERICA, hosted by legendary star of ... an entire short segment to the subject of diabetes. Diabetes is a debilitating health ... basis, but recent advancements in medical science may prove to be a significant breakthrough ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... management, Decatur County Memorial Hospital recently transitioned management companies to partner with Wound ... Management for their outpatient wound center. , Transitioning wound care management providers ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... East Primary Care Trust will be banned from smoking, even ... their identification// badge or uniform. The ban on smoking which ... and other people who visit the premises of the Trust. ... been called upon to give its approval for the new ...
... has called upon the NHS to make improvements in the ... that children who are terminally ill should not be compelled ... been issued by the Department of Health which insists ... which is inclusive of caring at home like nurse led ...
... the UT Southwestern Medical Center have found that brain ... them training using robotic treadmill. This is believed to ... paralysis following spinal cord injury. ,In the ... injured persons are capable of activating areas of brain ...
... that Alzheimer's disease represents a neuro-endocrine disorder that ... progresses // with severity of neuro-degeneration. ... the Journal of Alzheimer's Disease, researchers demonstrate that ... brain during the early stages of Alzheimer's disease, ...
... has to pay more attention to early detection and prevention ... terms of human lives//, according to experts participating in the ... the country. ,'Around 800,000 new cancer cases are being ... be on early detection and preventive care,' Surabhi Kakar, Secretary ...
... causes for the common depression have been identified by ... treatment for the ailment.// The major depressive disorder is ... quite a number of effective treatments for depression, even ... are not well known. ,William S. Gilmer, MD, ...
Cached Medicine News:Health News:Paralyzed Patients Can Be Trained To Walk With Robotic Treadmill 2Health News:Alzheimer's a new type of diabetes: Study 2Health News:India Needs To Pay More Attention To Detecting Cancer 2Health News:Causes Of Common Depression Identified 2